OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SPOP-mediated ubiquitination and degradation of PDK1 suppresses AKT kinase activity and oncogenic functions
Qiwei Jiang, Nana Zheng, Lang Bu, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

Complexities of Prostate Cancer
Sobia Wasim, Sang‐Yoon Lee, Jaehong Kim
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14257-14257
Open Access | Times Cited: 80

Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches
Fangfang Liu, Jingyu Chen, Kai Li, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 31

Targeting PI3K/Akt signaling in prostate cancer therapy
Mehrdad Hashemi, Afshin Taheriazam, Padideh Daneii, et al.
Journal of Cell Communication and Signaling (2022) Vol. 17, Iss. 3, pp. 423-443
Open Access | Times Cited: 45

S6K1-mediated phosphorylation of PDK1 impairs AKT kinase activity and oncogenic functions
Qiwei Jiang, Xiaomei Zhang, Xiaoming Dai, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 38

Multiple forms of cell death: A focus on the PI3K/AKT pathway
Jiawei Xu, Yu Li, Meili Kang, et al.
Journal of Cellular Physiology (2023) Vol. 238, Iss. 9, pp. 2026-2038
Closed Access | Times Cited: 25

Addressing the Reciprocal Crosstalk between the AR and the PI3K/AKT/mTOR Signaling Pathways for Prostate Cancer Treatment
Fabio Raith, Daniel H. O’Donovan, Clara Lemos, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2289-2289
Open Access | Times Cited: 23

AKT Blocks SIK1-Mediated Repression of STAT3 to Promote Breast Tumorigenesis
Zicheng Sun, Qiwei Jiang, Bing Gao, et al.
Cancer Research (2023) Vol. 83, Iss. 8, pp. 1264-1279
Open Access | Times Cited: 22

Master kinase PDK1 in tumorigenesis
Nana Zheng, Jiaqi Wei, Depei Wu, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 188971-188971
Closed Access | Times Cited: 18

ACE2 in chronic disease and COVID-19: gene regulation and post-translational modification
Chia-Wen Wang, Huai‐Chia Chuang, Tse‐Hua Tan
Journal of Biomedical Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 16

AMPK phosphorylates and stabilises copper transporter 1 to synergise metformin and copper chelator for breast cancer therapy
Xiaomei Zhang, Qiwei Jiang, Yaqing Su, et al.
British Journal of Cancer (2023) Vol. 128, Iss. 8, pp. 1452-1465
Closed Access | Times Cited: 15

Atypical inflammatory kinase IKBKE phosphorylates and inactivates FoxA1 to promote liver tumorigenesis
Bing Gao, Xueji Wu, Lang Bu, et al.
Science Advances (2024) Vol. 10, Iss. 6
Open Access | Times Cited: 5

Post-translational modifications on mitochondrial metabolic enzymes in cancer
Yunhua Peng, Huadong Liu, Jiankang Liu, et al.
Free Radical Biology and Medicine (2021) Vol. 179, pp. 11-23
Closed Access | Times Cited: 31

CRISPR Screen Contributes to Novel Target Discovery in Prostate Cancer
Takuya Tsujino, Kazumasa Komura, Teruo Inamoto, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 12777-12777
Open Access | Times Cited: 30

Novel insights into the SPOP E3 ubiquitin ligase: From the regulation of molecular mechanisms to tumorigenesis
Xian-Miao Li, Huanlei Wu, Qi‐Dong Xia, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 149, pp. 112882-112882
Open Access | Times Cited: 20

ELK3 destabilization by speckle-type POZ protein suppresses prostate cancer progression and docetaxel resistance
Cheol‐Jung Lee, Hee-Jung Lee, Seoree Kim, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 4
Open Access | Times Cited: 4

PI3K/Akt signaling in urological cancers: Tumorigenesis function, therapeutic potential, and therapy response regulation
Sahar Rezaei, Negin Nikpanjeh, Aryan Rezaee, et al.
European Journal of Pharmacology (2023) Vol. 955, pp. 175909-175909
Closed Access | Times Cited: 7

Phosphatase LHPP confers prostate cancer ferroptosis activation by modulating the AKT-SKP2-ACSL4 pathway
Guoqing Xie, Ningyang Li, Keqiang Li, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 9
Open Access | Times Cited: 2

Comprehensive analysis of TP53 and SPOP mutations and their impact on survival in metastatic prostate cancer
Jie Zhou, Yiming Lai, Shengmeng Peng, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 11

Functional roles of E3 ubiquitin ligases in prostate cancer
Yiting Zhao, Jinyun Li, Jun Chen, et al.
Journal of Molecular Medicine (2022) Vol. 100, Iss. 8, pp. 1125-1144
Closed Access | Times Cited: 9

MiR-22-3p regulates the proliferation, migration and invasion of colorectal cancer cells by directly targeting KDM3A through the Hippo pathway.
Ruiri Jin, Chunyan Zeng, Youxiang Chen
PubMed (2022) Vol. 37, Iss. 12, pp. 1241-1252
Closed Access | Times Cited: 9

Gene signature and prognostic value of ubiquitination-related genes in endometrial cancer
Ziwei Wang, Shuangshuang Cheng, Yan Liu, et al.
World Journal of Surgical Oncology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 5

Page 1 - Next Page

Scroll to top